This barrier is unrelated to the end of the transition period, following the United Kingdom's departure from the EU.


Inconsistent application of intellectual property rights and regulations

in United Arab Emirates

Trade barrier summary

Through the issuance of Decree 321, Intellectual Property (IP) protection for pharmaceutical products has seen progress. However, previously there has been inconsistent application of IP protection as UAE have insisted that innovation that innovator companies start filing for national patents, rather than recognising Country of Origin patents.

Sectors affected

  • Pharmaceuticals and biotechnology



Date reported

13 May 2019

Last updated

25 November 2021

Public ID


Back to search results

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.